x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Medical Digest & Congress Report

Medical Congress News

The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific

health & fitness

All Episodes

00:08:19

State of the Art Treatment in Lymphoma - report from...

Medical Digest & Congress Report ·

2024/12/22

Catherine S. Diefenbach, MD discusses the state of the art treatment in lymphoma care at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-lymphoma

en

00:09:21

Mastering the Art of Myelofibrosis Care: Expert...

Medical Digest & Congress Report ·

2024/12/22

Prof. Francesco Passamonti discusses the state of the art treatment in myelofibrosis Care at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:mastering-art-myelofibrosis-care-expert-guidance-clinical-experience-innovation-more-personalized-disease-control

en

00:08:50

Addressing Current Questions and Controversies in the...

Medical Digest & Congress Report ·

2024/12/20

Kerry A Rogers, MD discusses current questions and controversies in the management of chronic lymphocytic leukemia at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:addressing-current-questions-and-controversies-management-chronic-lymphocytic-leukemia

en

00:05:35

Addressing Current Questions and Controversies in the...

Medical Digest & Congress Report ·

2024/12/20

Michael J. Mauro, MD discusses current questions and controversies in the management of chronic myeloid leukemia at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:addressing-current-questions-and-controversies-management-chronic-myeloid-leukemia

en

00:05:30

State of the Art Treatment in Myelodysplastic...

Medical Digest & Congress Report ·

2024/12/20

Mikkael A. Sekeres, MD, MS discusses the state of the art treatment in MDS at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:state-art-treatment-myelodysplastic-syndromes

en

00:03:40

Five-Year Analysis of the POLARIX Study - report from...

Medical Digest & Congress Report ·

2024/12/20

Prof. Gilles Salles presented a 5-year analysis of the POLARIX study at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:five-year-analysis-polarix-study

en

00:05:00

Guiding Our Patient's Path: Managing First Relapse in...

Medical Digest & Congress Report ·

2024/12/20

Prof. Gilles Salles discusses managing first relapse in diffuse large B-Cell lymphoma outside of CAR-Ts at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:managing-first-relapse-diffuse-large-b-cell-lymphoma-outside-car-ts

en

00:07:17

Unraveling Data and Care Strategies for AL...

Medical Digest & Congress Report ·

2024/12/20

Vaishali Sanchorawala, MD review the clinical challenges and intricacies of care associated with the management of light chain amyloidosis. Video: https://medicaldigest.org/scientific-contents/interview:unraveling-data-and-care-strategies-al-amyloidosis

en

00:06:56

Bispecific Antibodies: A Playbook for...

Medical Digest & Congress Report ·

2024/12/20

Joshua Brody, MD discusses the advancing field of bispecific antibodies in third-line relapsed/refractory follicular lymphoma. Video: https://medicaldigest.org/scientific-contents/interview:bispecific-antibodies-playbook-relapsedrefractory-follicular-lymphoma

en

00:07:27

Smoking Tied to Worsened Disease Progression in...

Medical Digest & Congress Report ·

2024/12/20

Sangeetha Venugopal MD,MS discusses that smoking intensity and duration in patients with myelodysplastic syndromes were tied to distinct genetic mutations, higher mutation burden, and worse survival outcomes, according to a study presented at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:smoking-tied-worsened-disease-progression-myelodysplastic-syndromes

en

00:10:56

Addressing Current Questions and Controversies...

Medical Digest & Congress Report ·

2024/12/20

Martin Hutchings, MD, PhD discusses the role of CAR T-Cell therapy and bispecific antibodies in the management of lymphoma at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:addressing-current-questions-and-controversies-regarding-role-car-t-cell-therapy-and-bispecific-antibodies-management-lymphoma

en

00:04:58

Estrogen Receptor Mutations in HR+ Advanced Breast...

Medical Digest & Congress Report ·

2024/12/20

Virginia Kaklamani, MD, DSc discusses estrogen receptor mutations in HR+ advanced breast cancer and generation practice recommendations on mutation screening to guide therapeutic decisions at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scientific-contents/interview:estrogen-receptor-mutations-hr-advanced-breast-cancer-next-generation-practice-recommendations-mutation-screening-guide-therapeutic-decisions

en

00:02:02

Anthracyclines May Improve Survival in High-Risk...

Medical Digest & Congress Report ·

2024/12/20

Nan Chen, MD explains patients with early-stage, node-negative, hormone receptor positive, HER2- negative breast cancer who have a high risk of recurrence based on the OncotypeDX genomic test had better outcomes when treated with adjuvant anthracycline- plus taxane-based chemotherapy regimens compared with those receiving adjuvant taxane-based chemotherapy regimens alone, according to results at San Antonio Breast Cancer Symposium 2024. Video:

en

00:03:17

Immunotherapy: Explore Inroads for ER-positive...

Medical Digest & Congress Report ·

2024/12/20

Heather McArthur, MD, MPH discusses immunotherapy panel discussion to explore inroads for ER-positive disease, challenges ahead at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scientific-contents/interview:immunotherapy-explore-inroads-er-positive-disease-challenges-ahead

en

00:04:37

The Winding Road of Immune Biomarkers in Early Breast...

Medical Digest & Congress Report ·

2024/12/20

Sherene Loi, MD discusses immune biomarkers in early breast cancer at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scientific-contents/interview:winding-road-immune-biomarkers-early-breast-cancer

en

00:04:35

Palbociclib Plus Endocrine Therapy Beats Chemo in...

Medical Digest & Congress Report ·

2024/12/20

Prof. Sibylle Loibl presented the findings from the phase 3 PADMA clinical trial at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scientific-contents/interview:palbociclib-plus-endocrine-therapy-beats-chemo-hrher2-metastatic-breast-cancer

en

00:02:34

COMET Trial Finds Active Monitoring Is a Viable...

Medical Digest & Congress Report ·

2024/12/20

Shelley Hwang, MD, MPH discusses active monitoring instead of upfront surgery may be a viable option for patients with hormone receptor-positive, HER2-negative, low-risk DCIS, according to results presented at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scientific-contents/interview:comet-trial-finds-active-monitoring-viable-option-some-patients-low-risk-dcis

en

00:04:38

Palbociclib Shows Benefit in HR+ HER2+ Metastatic...

Medical Digest & Congress Report ·

2024/12/20

Otto Metzger, MD presented late-breaking results of the phase 3 PATINA trial showing addition of CDK4/6 inhibitor palbociclib to standard therapy led to a 15-month improvement in PFS in HR+, HER2+ metastatic breast cancer at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scientific-contents/interview:palbociclib-shows-benefit-hr-her2-metastatic-breast-cancer-patina-trial

en

00:04:46

Breast Cancer in Young Women - report from SABCS2024

Medical Digest & Congress Report ·

2024/12/20

Matteo Lambertini, MD, PhD discusses an educational session focus on the management of breast cancer in young women at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scientific-contents/interview:breast-cancer-young-women

en

00:03:49

The Future of Cancer Genetics Is Here - Reversion...

Medical Digest & Congress Report ·

2024/12/20

Katherine L. Nathanson, MD discusses reversion mutations in BRCA1/2 in response to therapy at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scientific-contents/interview:future-cancer-genetics-here-reversion-mutations-brca12-response-therapy

en

317 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown